AUS
NZ
UK
CA
USA
IND
Healthcare
Sigma Healthcare Provides An Update On API Proposal
March 13, 2019 02:15 PM AEDT| By Team Kalkine MediaThe Board of Sigma Healthcare Limited (ASX: SIG) believes that the current API proposal is not reflecting the long-term prospects and value inherent in Sigma, which is why the Board has concluded that the current API proposal is not in the best inter...
Ellex Medical’s Shares Uplifted On ASX After Announcing The Results Of Its LiGHT’s Clinical Trial
March 12, 2019 06:47 PM AEDT| By Team Kalkine MediaLeading medical technology company, Ellex Medical Lasers Limited (ASX: ELX) have announced the results of Laser in Glaucoma and Ocular HyperTension (LiGHT) clinical trial which demonstrated that selective laser trabeculoplasty (SLT) is safe and effec...
Cynata to go Ahead with their Phase 2 Clinical Trial Post Favourable Advice from MHRA
March 12, 2019 04:58 PM AEDT| By Team Kalkine MediaCynata Therapeutics (ASX: CYP) is an Australian biotechnology company which is in the business of researching and manufacturing regenerative medicine targeted towards the development of therapies based on a proprietary therapeutic stem cell platform...
Zelda Therapeutics Enters Binding Agreement With Ilera For Deriving Advantage in Commercialisation
March 12, 2019 04:29 PM AEDT| By Team Kalkine MediaZelda Therapeutics Limited (ASX: ZLD) is a cannabis group which works on a varied range of formulations based on cannabinoid for treating several medical conditions. It specializes in the development of medicines which are used for the treatment of t...
Opthea Limited Announces the Addition of OPT ticker in All Ordinaries, Effective from March 18, 2019
March 12, 2019 02:59 PM AEDT| By Team Kalkine MediaOpthea Limited (ASX: OPT) is into biotechnology. The company is into the development of a novel biologic therapy, OPT-302, which is used for the treatment of eye diseases, by blocking two members of the vascular endothelial growth factor family VEGF-...
Starpharma strengthens its cash positions on the receipt of $4.0 million tax refund
March 12, 2019 02:42 PM AEDT| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) announced that the company has received the Research & Development Tax Incentive refund of $4.0 million from the Australian Government. The refund relates to the costs of Research and Development activities...
Althea Group Announced Investor Update And Board Changes
March 11, 2019 05:03 PM AEDT| By Team Kalkine MediaAn Australian owned licensed importer and producer of medical cannabis, Althea Group Holdings Ltd (ASX: AGH) has published a presentation for the investors on 7 March 2019. The presentation contains an update about AGH?s operations and product range,...
Bod Australia implements LOI with Tilman S.A; stock up on ASX
March 11, 2019 04:04 PM AEDT| By Team Kalkine MediaBod Australia Limited (ASX: BDA), based in Double Bay, develops, produces and commercialises plant-based extracts including medicinal cannabis, health and supplement products, as well as skin-care solutions across the Australian market. The company h...
Wattle Health included in the ASX All Ordinaries Index as part of Quarterly Index Rebalancing
March 11, 2019 03:12 PM AEDT| By Team Kalkine MediaWattle Health Australia Limited (ASX: WHA) is in the business of offering organic and sustainable products for promoting health and wellness at all stages and is aspiring to become globally recognised for its superior quality offerings. The company u...
Do these 2 Healthcare Stocks look Exciting from Technical Momentum Perspective – NUH, BNO?
March 10, 2019 06:03 AM AEDT| By Team Kalkine MediaFor buying any security/scrip, one of the most important aspects to look for is the momentum of the security. It should be noted that momentum should not to be confused with the trend. A trend is the overall direction of the security in which it is m...
5 Biotech/ Healthcare Stocks - ELX, EXL, PSQ, MSB And RHC
March 09, 2019 10:30 AM AEDT| By Team Kalkine MediaEllex Medical Lasers Ltd Losses Narrowed in 1H 2019: Ellex Medical Lasers Ltd (ASX: ELX), eye disease equipment manufacturer, for the first half of FY 19, has reported 9% growth in the group revenue to $41.6 million on the back of 18% rise in the gl...
Immutep Announced Positive Results For Its Preclinical Study Of IMP761 At The 14th ECCO Conference
March 08, 2019 05:03 PM AEDT| By Team Kalkine MediaImmutep Limited (ASX: IMM) is in the business of manufacturing biotechnology products, operating in Europe, Australia, and the U.S. The company develops immunotherapeutic products for the treatment of cancer, and autoimmune disease. The company helps...
Zoono Group Announces Proceedings Against Stayzon
March 08, 2019 03:51 PM AEDT| By Team Kalkine MediaZoono Group Limited (ASX: ZNO) announced that Stayzon Retail Ventures Pty Limited has been placed into Voluntary Liquidation by its Directors, Shaun David Bell, and Christopher Plastow. As previously stated, Zoono instigated legal action against Sta...
Medibio’s Ilumen™ Successfully Completes Its First Commercial Program.
March 08, 2019 01:24 PM AEDT| By Team Kalkine MediaMedibio Limited (ASX: MEB), a healthcare company engaged into the development of diagnostic heart rate variability technology for mental health diagnosis, has announced the results of the latest release of ilumen?, which is a corporate health product...
AusCann Group Holdings Publishes Its Investor Presentation
March 07, 2019 07:43 PM AEDT| By Team Kalkine MediaAusCann Group Holdings Ltd (ASX: AS8) operates as a holding company. The Company, through its subsidiaries, develops cannabis-based medical products. AusCann Group Holdings produces and sells cannabinoid medicines for application in anti-convulsion,...
Wattle Health Australia Announces The Appointment Of Dr. Tony Mckenna As The CEO of CBDG
March 07, 2019 03:02 PM AEDT| By Team Kalkine MediaWattle Health Australia Ltd (ASX: WHA) provides Australian made health and wellness products to its customers. In April 2018, the company completed a Joint Venture Agreement with the organic dairy farmers (ODFA) to form Corio Bay Dairy Group (CBDG)....
Cardiex announced the extension of Atcor Medical’s pharma contract with Bayer Ag
March 07, 2019 02:38 PM AEDT| By Team Kalkine MediaCardiex Limited (ASX: CDX), a healthcare company engaged into the development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management, announced the extension and expansion of a previous contract awarded to it...
Immutep Limited To Present At Oppenheimer Healthcare Conference
March 07, 2019 02:20 PM AEDT| By Team Kalkine MediaImmutep Limited (ASX: IMM) operates as a biotechnology company. Immutep offers its services worldwide. The company has recently stated the details about its participation in Oppenheimer?s 29th Annual Healthcare Conference. The CEO of the company Mr...
Orthocell Reports On-Track Status Of Ortho-ATI’s Shoulder Tendon Clinical Trial
March 06, 2019 03:51 PM AEDT| By Team Kalkine MediaOrthocell Limited (ASX: OCC) is in the business of developing regenerative medicines. The company?s key focus is developing medicines for regenerating mobility for patients by targeting the repair of a variety of soft tissue injuries. The company?s...
Zelda Therapeutics Announces Patent For Novel Prognostic Biomarker For Breast Cancer
March 06, 2019 03:00 PM AEDT| By Team Kalkine MediaZelda Therapeutics Ltd?(ASX: ZLD) announces the grant of a new patent for novel prognostic biomarker for breast cancer, a method to predict disease-free survival. The patent is valid until 2038. Post the announcement, the shares soared up by 3.57% o...
Advertise your brand on Kalkine Media